FibroGen, Inc.
FGEN
$6.89
-$0.03-0.43%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -74.20% | 205.26% | -9.91% | 52.80% | 41.43% |
| Total Depreciation and Amortization | -7.10% | -52.37% | -5.38% | -4.76% | -56.27% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 433.50% | -107.82% | 140.75% | -21.12% | -26.62% |
| Change in Net Operating Assets | 88.17% | -837.95% | 83.32% | 10.34% | -227.73% |
| Cash from Operations | 108.92% | -263.73% | 78.99% | 32.75% | -223.61% |
| Capital Expenditure | 88.65% | -71.95% | -485.71% | 51.72% | 88.45% |
| Sale of Property, Plant, and Equipment | -- | -75.39% | 27,800.00% | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -100.00% | 40.82% | 388.95% |
| Cash from Investing | -100.93% | 128.21% | -98.95% | 40.88% | 400.64% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -25.00% | 75.00% | -100.00% | 33.33% | 77.78% |
| Issuance of Common Stock | -- | -- | -100.00% | -- | -- |
| Repurchase of Common Stock | -164.29% | 87.39% | -46.05% | 50.33% | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -1,860.00% | 103.94% | -496.88% | 119.39% | 32.93% |
| Foreign Exchange rate Adjustments | 1,717.24% | 95.57% | -176.14% | 1,056.05% | -79.71% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 113.95% | -196.83% | -127.76% | 539.78% | -10.07% |